相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prescribing efficiency of proton pump inhibitors in China: influence and future directions
Wenjie Zeng et al.
BMC HEALTH SERVICES RESEARCH (2015)
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Brian Godman et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2015)
Managed entry agreements for pharmaceuticals in Australia
Agnes Vitry et al.
HEALTH POLICY (2014)
Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications
Andrew Martin et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2014)
Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction
Wenjie Zeng et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2014)
Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review
Ana Caires de Souza et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2014)
HEALTH TECHNOLOGY REASSESSMENT: THE ART OF THE POSSIBLE
Gail MacKean et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2013)
CASE STUDIES THAT ILLUSTRATE DISINVESTMENT AND RESOURCE ALLOCATION DECISION-MAKING PROCESSES IN HEALTH CARE: A SYSTEMATIC REVIEW
Julie Polisena et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2013)
A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security
Lionel Riou Franca et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Performance-Based Risk-Sharing Arrangements-Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force
Louis P. Garrison et al.
VALUE IN HEALTH (2013)
The impacts of health insurance on health care utilization among the older people in China
Xin Li et al.
SOCIAL SCIENCE & MEDICINE (2013)
Financial burden of household out-of pocket health expenditure in Viet Nam: Findings from the National Living Standard Survey 2002-2010
Hoang Van Minh et al.
SOCIAL SCIENCE & MEDICINE (2013)
Does perverse economic incentive lead to the irrational uses of medicines?
Wenhui Mao et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries
Brian Godman et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
The reform of the essential medicines system in China: A comprehensive approach to universal coverage
Sarah L. Barber et al.
JOURNAL OF GLOBAL HEALTH (2013)
Multilevel Analysis of the Influence of Patients' and General Practitioners' Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France
Sylvain Pichetti et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2013)
Breaking up is hard to do: why disinvestment in medical technology is harder than investment
Marion Haas et al.
AUSTRALIAN HEALTH REVIEW (2012)
Controlling cost escalation of healthcare: making universal health coverage sustainable in China
Shenglan Tang et al.
BMC PUBLIC HEALTH (2012)
International variability in the reimbursement of cancer drugs by publically funded drug programs
P. K. Cheema et al.
CURRENT ONCOLOGY (2012)
Overprescribing In China, Driven By Financial Incentives, Results In Very High Use Of Antibiotics, Injections, And Corticosteroids
Yongbin Li et al.
HEALTH AFFAIRS (2012)
Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
K. Claxton et al.
HEALTH TECHNOLOGY ASSESSMENT (2012)
NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium
John A. Ford et al.
BMJ OPEN (2012)
Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998-2010
Sylvain Pichetti et al.
HEALTH POLICY (2011)
Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey
Anita K. Wagner et al.
HEALTH POLICY (2011)
Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study
Martin H. Thornhill et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
NICE on disinvestment NICE recommendations for disinvestment
William Hollingworth et al.
BRITISH MEDICAL JOURNAL (2011)
Serve the people or close the sale? Profit-driven overuse of injections and infusions in China's market-based healthcare system
Lucy Reynolds et al.
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2011)
Generic and therapeutic substitutions in the UK: are they a good thing?
Martin G. Duerden et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers
Josh J. Carlson et al.
HEALTH POLICY (2010)
Funding the Unfundable Mechanisms for Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies into Healthcare Systems
Tania Stafinski et al.
PHARMACOECONOMICS (2010)
Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus
Alain Weill et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications
Diane McGinn et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
Brian Godman et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
Ongoing Pharmaceutical Reforms in France Implications for Key Stakeholder Groups
Catherine Sermet et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2010)
High prices for generics in Australia - more competition might help
Liliana Bulfone
AUSTRALIAN HEALTH REVIEW (2009)
Health Technology Assessment: Lessons Learned from Around the World-An Overview
John C. O'Donnell et al.
VALUE IN HEALTH (2009)
Applying Programme Budgeting Marginal Analysis in the health sector: 12 years of experience
Rachel Grocott
Expert Review of Pharmacoeconomics & Outcomes Research (2009)
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator
Mike Boggild et al.
BRITISH MEDICAL JOURNAL (2009)
Enhancing the rational use of new medicines across European health care systems
Silvio Garattini et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Pharmaceutical policy in China
Qiang Sun et al.
HEALTH AFFAIRS (2008)
The implications of regional variations in medicare spending. Part 1: The content, quality, and accessibility of care
ES Fisher et al.
ANNALS OF INTERNAL MEDICINE (2003)
分享论文
